Staff Data Search - جامعة الزقازيق

Personal Website
Curriculum Vitae

Nora Gamal Mohamed Abdallah Essa

Faculty pharmacy - Department Pharmaceutics Department

BSc In NULL, [2005]
MSc In NULL, [2010]
PhD In NULL, [2016]

معار

Academic Jobs

معيد : 3/10/2005
Doctor Assisant : 23/1/2011
Doctor : 26/4/2016
Professor Assisant : 22/3/2022
استاذ مساعد لقب علمى : 22/3/2022

Publications

1 - Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides (2014).

2 - Buccoadhesive tablets for delivery of verapamil Hcl: Design, in-vitro analysis and in-vivo evaluation (2012).

3 - Fast disintegrating tablet of Doxazosin Mesylate nanosuspension: Preparation and characterization (2020).

4 - Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study (2019).

5 - Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs (2021).

6 - New approach for administration of doxazosin mesylate: comparative study between liquid and solid self-nanoemulsifying drug delivery systems (2021).

7 - Morphologic design of sugar-based polymer nanoparticles for delivery of antidiabetic peptides (2021).

8 - Intratracheal administration of chloroquine-loaded niosomes minimize systemic drug exposure (2021).

9 - Development of Potent Nanosized Isatin-isonicotinohydrazide Hybrid for Management of Mycobacterium Tuberculosis (2022).

10 - EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide (2020).

11 - Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations (2022).

12 - Niosomal and ethosomal gels: A comparative in vitro and ex vivo evaluation for repurposing of spironolactone (2022).

13 - Methods for preparation of nanostructured lipid carriers (2022).

14 - Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors (2022).

15 - Morphologic design of nanostructures for enhanced antimicrobial activity (2022).

16 - Design of Nanoconstructs that Exhibit Enhanced Hemostatic Efficiency and Bioabsorbability (2022).

17 - Nanomaterials and immune system (2022).

18 - Methods for preparation of niosomes: A focus on thin-film hydration method (2022).

19 - Brain-targeted delivery of Valsartan using solid lipid nanoparticles labeled with Rhodamine B; a promising technique for mitigating the negative effects of stroke (2023).

20 - Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control (2023).

21 - Intranasal thermosensitive hydrogel of agomelatine solid dispersion for better management of depression (2023).

22 - Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain (2023).

23 - Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs (2023).

24 - Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: Effect on ocular retention and intraocular pressure (2023).

25 - Machine learning algorithms for prediction of entrapment efficiency in nanomaterials (2023).

26 - Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain (2023).

27 - In vitro and in vivo studies of Syzygium cumini-loaded electrospun PLGA/PMMA/collagen nanofibers for accelerating topical wound healing (2024).

28 - Electrospun Tamarindus indica-loaded antimicrobial PMMA/cellulose acetate/PEO nanofibrous scaffolds for accelerated wound healing: in-vitro and in-vivo assessments (2024).

29 - Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes (2024).

30 - Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems (2023).

31 - Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems (2024).

32 - 24 Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation. (2024).

33 - Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes (2024).

Research Area